HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W Plunkett Selected Research

9-beta-D-arabinofuranosylguanosine 5'-triphosphate

4/2001Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells.
8/2000High-performance liquid chromatography method for the determination and quantitation of arabinosylguanine triphosphate and fludarabine triphosphate in human cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W Plunkett Research Topics

Disease

8Neoplasms (Cancer)
10/2008 - 03/2000
7Leukemia
03/2012 - 08/2000
5B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2006 - 01/2000
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2012 - 02/2001
3Hematologic Neoplasms (Hematological Malignancy)
10/2008 - 03/2000
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
03/2012
1Opportunistic Infections (Opportunistic Infection)
09/2002
1Infections
09/2002
1Sarcoma (Soft Tissue Sarcoma)
08/2001
1Ascites
10/2000
1Meningism (Meningismus)
01/2000
1Vomiting
01/2000
1Breast Neoplasms (Breast Cancer)
01/2000
1Neoplasm Metastasis (Metastasis)
01/2000
1Nausea
01/2000

Drug/Important Bio-Agent (IBA)

6DNA (Deoxyribonucleic Acid)IBA
04/2006 - 08/2000
6fludarabineIBA
09/2002 - 08/2000
5GemcitabineFDA Link
12/2001 - 03/2000
3NucleosidesIBA
10/2008 - 02/2001
3Cytarabine (Cytosar-U)FDA LinkGeneric
04/2006 - 01/2000
3nelarabine (506U78)FDA Link
04/2001 - 03/2000
22'- cyano- 2'- deoxyarabinofuranosylcytosineIBA
06/2001 - 04/2001
29-beta-D-arabinofuranosylguanosine 5'-triphosphateIBA
04/2001 - 08/2000
29-arabinofuranosylguanineIBA
04/2001 - 03/2000
2ProdrugsIBA
04/2001 - 03/2000
1MRx102IBA
03/2012
1Apoptosis Regulatory ProteinsIBA
03/2012
1triptolideIBA
03/2012
1AntimetabolitesIBA
10/2008
1Drug CombinationsIBA
04/2006
1tanespimycin (17AAG)IBA
04/2006
1Arsenic Trioxide (Trisenox)FDA Link
04/2006
1purineIBA
09/2002
1fludarabine phosphate (Fludara)FDA LinkGeneric
09/2002
1AcidsIBA
09/2002
1perfosfamideIBA
11/2001
1Clofarabine (Clolar)FDA Link
11/2001
1Alkylating AgentsIBA
11/2001
1gemcitabine triphosphateIBA
08/2001
1Guanosine Triphosphate (GTP)IBA
08/2001
1triphosphoric acid (triphosphate)IBA
04/2001
1Cytostatic AgentsIBA
02/2001
12',2'-difluoro-2'-deoxyuridineIBA
10/2000
1Free RadicalsIBA
09/2000
1Superoxide DismutaseIBA
09/2000
1Cytochromes c (Cytochrome c)IBA
09/2000
12-fluoro-araATPIBA
08/2000
1Perchloric AcidIBA
08/2000
1RNA (Ribonucleic Acid)IBA
08/2000
1NucleotidesIBA
08/2000
1Antisense RNA (Anti-Sense RNA)IBA
03/2000
1GuanineIBA
03/2000
1Antineoplastic Agents (Antineoplastics)IBA
03/2000
1Cisplatin (Platino)FDA LinkGeneric
03/2000
1CaspasesIBA
01/2000
1AdenineFDA LinkGeneric
01/2000

Therapy/Procedure

2Therapeutics
04/2001 - 02/2001
1Salvage Therapy
09/2002